local_hospital

Praxis Prof. Vent

Address
Alteburger Str. 336, 50968 Cologne, Germany

Praxis Prof. Vent - Allergology and Immunotherapy Research

Praxis Prof. Vent is a specialized clinical research center focused on allergology and immunotherapy. The center conducts advanced clinical trials investigating innovative treatment approaches for respiratory allergic diseases, with particular expertise in allergen-specific immunotherapy and allergic rhinitis management.

  • Subcutaneous allergen immunotherapy with novel allergoid formulations
  • Birch pollen-induced allergic rhinitis and rhinoconjunctivitis
  • Seasonal allergic respiratory disease management

The research center participates in prospective, randomized, double-blind placebo-controlled trials evaluating the clinical efficacy of advanced immunotherapeutic agents. Their work includes assessment of symptom reduction and medication requirements during peak pollen seasons, contributing to the development of more effective treatments for adolescents and adults suffering from allergen-induced respiratory conditions.

Site Overview

assignment
1
connected trial
corporate_fare
1
sponsor
science
24
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
1
Total trials linked
Low Activity
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 1 therapeutic areas and 15 of 24 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
1
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
1
Outperforms 2% of sites
public
Therapeutic diversity
1areas
Outperforms 2% of sites
groups
Sponsor diversity
1sponsors
Outperforms 2% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Praxis Prof. Vent

Trial Sponsor Phase Status Start Date End Date
Subcutaneous Administration of Mannan-Conjugated Birch Pollen Allergoids in Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or RhinoconjunctivitisInmunotek S.L.Phase IIINot RecruitingOct 2024Jun 2025

IMP list

lock Showing 1 of 24 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Azelastine Hydrochloride1Unknown2024-10-282024-10-28

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.